Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.290
-0.010 (-0.77%)
Apr 1, 2025, 10:03 AM EDT - Market open
Envoy Medical Revenue
In the year 2024, Envoy Medical had annual revenue of $225.00K, down -28.80%. Envoy Medical had revenue of $42.00K in the quarter ending December 31, 2024, a decrease of -55.79%.
Revenue (ttm)
$225.00K
Revenue Growth
-28.80%
P/S Ratio
108.57
Revenue / Employee
$6,618
Employees
34
Market Cap
27.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 225.00K | -91.00K | -28.80% |
Dec 31, 2023 | 316.00K | 79.00K | 33.33% |
Dec 31, 2022 | 237.00K | -73.00K | -23.55% |
Dec 31, 2021 | 310.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCOCH News
- 1 day ago - Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results - Newsfile Corp
- 15 days ago - Hearing Device Coverage Clarification Act Reintroduced in House and Senate - Newsfile Corp
- 20 days ago - Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device - Newsfile Corp
- 22 days ago - Envoy Medical to Participate in the 37th Annual ROTH Conference - Newsfile Corp
- 5 weeks ago - First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant - Newsfile Corp
- 6 weeks ago - Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - Newsfile Corp
- 3 months ago - Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study - Newsfile Corp
- 4 months ago - Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events - GlobeNewsWire